<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03038958</url>
  </required_header>
  <id_info>
    <org_study_id>AK160324627AD</org_study_id>
    <nct_id>NCT03038958</nct_id>
  </id_info>
  <brief_title>Comparison of Hyperbaric Prilocaine With Chloroprocaine for Intrathecal Anaesthesia in Day Case Knee Arthroscopy</brief_title>
  <official_title>Comparison of Hyperbaric Prilocaine With Chloroprocaine for Intrathecal Anaesthesia in Day Case Knee Arthroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Saint Pierre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hôpital de Braine-l'Alleud</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire Saint Pierre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares intrathecal 1% plain chloroprocaine with intrathecal 2% hyperbaric
      prilocaine for patients undergoing ambulatory knee arthroscopy in terms of efficacy and side
      effects
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Onset time of sensory block</measure>
    <time_frame>up to 30 minutes</time_frame>
    <description>The level of sensory block will be determined at 5, 10, 20 and 30 minutes after intrathecal injection. The level of sensory block will be assessed as loss of sensation to pinprick and cold.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Onset time of motor block</measure>
    <time_frame>up to 30 minutes</time_frame>
    <description>The level of motor block will be determined at 5, 10, 20 and 30 minutes after intrathecal injection. The level of motor block will be assessed by using the Bromage Scale.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Pain assessed by Visual Analog Scale</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>Pain levels will be determined at the inflation of tourniquet, at the incision and every 10 minutes in the PACU (Post Anesthesia Care Unit). Visual Analog pain score (scale = 0 no pan; 10 = worst pain imaginable).</description>
  </other_outcome>
  <other_outcome>
    <measure>Side-effects (nausea and vomiting)</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>Assessed after intervention and the day after by phone</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Knee Arthroscopy</condition>
  <condition>Spinal Anesthesia</condition>
  <arm_group>
    <arm_group_label>Isobaric 2-chloroprocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The 50 mg dose of isobaric 2-chloroprocaine will be administered to patients undergoing ambulatory knee arthroscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperbaric prilocaine 2%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The dose of 50 mg of Hyperbaric prilocaine 2% will be administered to patients undergoing ambulatory knee arthroscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isobaric 2-chloroprocaine</intervention_name>
    <description>intrathecal injection of 50 mg isobaric 2-Chloroprocaine</description>
    <arm_group_label>Isobaric 2-chloroprocaine</arm_group_label>
    <other_name>Ampres</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyperbaric prilocaine</intervention_name>
    <description>intrathecal injection of 50 mg hyperbaric prilocaine 2%</description>
    <arm_group_label>Hyperbaric prilocaine 2%</arm_group_label>
    <other_name>Tachipri</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiology physical status (ASA) ≤ III

          -  Age 18-80 year

          -  Height between 160 and 185 cm

          -  Signed informed consent obtained prior to any study specific assessments and
             procedures

        Exclusion Criteria:

          -  Cardiac pathology (such as Heart failure, Aortic stenosis)

          -  Coagulation disorders (INR&gt;1.3, platelet &lt; 80 000/mm3)

          -  Known allergy to local anaesthetics

          -  Disagreement of the patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel Guntz, MD</last_name>
    <role>Study Director</role>
    <affiliation>Université Libre de Bruxelles (ULB), Braine-l'Alleud Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Panayota Kapessidou, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Saint-Pierre (CHU Saint-Pierre), Université Libre de Bruxelles (ULB)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Braine-l'Alleud Hospital</name>
      <address>
        <city>Braine-l'Alleud</city>
        <zip>1420</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Saint-Pierre</name>
      <address>
        <city>Brussels Capital Region</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2017</study_first_submitted>
  <study_first_submitted_qc>January 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2017</study_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Local Anaesthetic</keyword>
  <keyword>spinal anesthesia</keyword>
  <keyword>Knee arthroscopy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Prilocaine</mesh_term>
    <mesh_term>Chloroprocaine</mesh_term>
    <mesh_term>Procaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

